MHRA Drug Safety Update May 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 10 May 2022) has been published and includes articles on:

  • Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia
  • COVID-19 vaccines and medicines: updates for May 2022
  • Letters and medicine recalls sent to healthcare professionals in April 2022

To see the latest MHRA Drug Safety Updates in full, visit the website